Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0N8RT
|
|||
| Former ID |
DNC013312
|
|||
| Drug Name |
Cyclopentyl(5-(pyridin-2-yl)oxazol-2-yl)methanone
|
|||
| Synonyms |
alpha-ketooxazole, 14e; cyclopentyl(5-(pyridin-2-yl)oxazol-2-yl)methanone; SCHEMBL711639; CHEMBL376397; BDBM23134; CZXHLRXAHDZQJF-UHFFFAOYSA-N
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C14H14N2O2
|
|||
| Canonical SMILES |
C1CCC(C1)C(=O)C2=NC=C(O2)C3=CC=CC=N3
|
|||
| InChI |
1S/C14H14N2O2/c17-13(10-5-1-2-6-10)14-16-9-12(18-14)11-7-3-4-8-15-11/h3-4,7-10H,1-2,5-6H2
|
|||
| InChIKey |
CZXHLRXAHDZQJF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fatty acid amide hydrolase (FAAH) | Target Info | Inhibitor | [1] |
| BioCyc | Anandamide degradation | |||
| KEGG Pathway | Retrograde endocannabinoid signaling | |||
| Panther Pathway | Anandamide degradation | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase. J Med Chem. 2007 Jul 12;50(14):3359-68. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.